Manjit Sareen reflects on the first Asia-Pacific

Vaccine selectively targets toxic forms of amylo

Harness Therapeutics has unveiled its second-gene

Algen Biotechnologies is combining CRISPR and AI

At LIC 2025, investors, scientists and founders

The DripBar, an intravenous vitamin therapy franc

Evelyne Bischof on cognition, biomarkers and the

Cirrus Therapeutics lands seed funding to advanc

Klotho Neurosciences today announced it has signe

LifeVantage Corporation said it has closed its pr

Longevity biotech seeks to broaden its therapeut

Derm-Biome’s compound prevented epidermal thic

While life insurance covers deaths from skydiving,

Chrysea and KaloCyte have entered into an exclusi

Emagene Life announced a global partnership with

Omada Health has introduced Meal Map, an AI-based

Myrtelle has published interim results from its P

C2N Diagnostics has submitted a regulatory filing

Rokit America, the U.S.

Biomed Industries presented Phase 2 clinical data

Alnylam has dosed the first patient in ZENITH, it

BIOARMOR reaches XPRIZE Healthspan semifinals wi

Startup’s ‘brain shuttle’ tech is designed

Cognision has entered a strategic partnership wit

Anavex Life Sciences has published a preprint of

Biograph and Caristo Diagnostics announced the la

Biograph partners with Caristo Diagnostics to br

Agency responds to petition by Natural Products

Investments in neurodegeneration-focused startup

Alnylam Pharmaceuticals has released new post hoc

Grand Palais will host Europe’s longevity summ

Company targets confirmatory trials of immunomod

Clene Inc.

L-Nutra and Parsley Health announced a strategic

Seoul — Sky Labs has launched CART BP, a ring-t

Fractyl Health has released data from its REMAIN-

GenSight Biologics has completed a fundraising ro

Sunrise has secured $29 million in a funding roun

AdVantage Therapeutics said it has been awarded a

AbbVie has filed a New Drug Application (NDA) wit

GlycanAge’s Gordan Lauc on individuality, biol

Expanding from oncology into neurodegeneration,

New peer-reviewed data reinforce that C2N’s Pre

Aspen Neuroscience has launched Cohort 3 of its A

Epirium Bio, a clinical-stage biopharmaceutical c

YouthBio Therapeutics has received positive feedb

Designs for Health has introduced Anaerostipes Pr

New certificate series aims to empower students

United Space Structures Founder Bill Kemp on why

YouthBio receives positive FDA feedback on thera